AUG 7·SEC EDGARLow
Holt Jason sold $349K of UFPT
Holt Jason (Vice President) sold 1,100 shares of UFP TECHNOLOGIES INC (UFPT) at $317.00 ($0.35M total) on 2026-08-06.
StockNASDAQ · US · USDHealthcare · Medical Devices
$UFPT
UFP TECHNOLOGIES INC
Price · $UFPTvia TradingView
AI sentiment · 7d5 articles
- Bullish
- 4
- Neutral
- 1
- Bearish
- 0
Top stories · $UFPTMore →
AUG 6·yahoo.com
Why UFP Technologies Stock Is Skyrocketing Today
UFP Technologies (NASDAQ: UFPT) shares rose about 24% by 2 p.m. ET after the company reported strong Q2 results. UFP said sales grew 15%, adjusted EPS rose 17%, and revenue increased 15% to its five largest customers. The company also reported 12% organic growth and 20% growth in its core medtech unit, and is monitoring tuck-in acquisitions.
AUG 5·rttnews.com
Biotech Stocks At 52-Week Highs - UFPT +25%, INFU +33%, SOPH +20% On Q2 Reports, REPL, PBLS
Biotech stocks hit 52-week highs Aug 4, 2026 after Q2 results or regulatory updates. UFP Technologies (UFPT) rose over 25% to $338.70, reporting Q2 net income $20.9M and sales $174M. InfuSystem (INFU) gained 33% to $12.49 on $36.9M Q2 revenue and 2026 guidance. Replimune (REPL) jumped to $13.86 after a favorable BLA opinion. SOPHiA (SOPH) rose to $6.98 with $23.3M Q2 revenue and 2026 outlook. Parabilis (PBLS) reached $36.69.
UFPT sentiment & insider activity
Over the past 7 days, alphai's AI scored 5 news stories mentioning UFPT (UFP TECHNOLOGIES INC). Coverage has skewed bullish: 4 bullish, 1 neutral, and 0 bearish.
Recent UFPT coverage spans earnings, insider activity and financial news.
In the last 30 days, UFPT insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($349K). The most active reporter was Holt Jason, Vice President, with 1 filing.
What's driving UFPT
This is a routine insider open-market sale with no 10b5-1 plan disclosed, but it does not by itself signal a fundamental change.
The article frames a strong Q2 beat with multiple growth metrics and no 2026 guidance, supporting continued momentum but raising valuation sensitivity.
Q2 earnings and sales growth appear to be the immediate catalyst behind the breakout to a 52-week high.
The article attributes the sharp rally to an earnings beat with stronger profitability metrics, suggesting near-term momentum and upward estimate revisions risk.
Beat on both revenue and non-GAAP EPS supports near-term upside bias, but the article flags expected revenue deceleration to 4.3% growth.
alphai scores every news story that mentions UFPT with an AI model for sentiment and relevance, and aggregates insider trades from UFP TECHNOLOGIES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $UFPT
Score
Holt Jason sold $349K of UFPT
Holt Jason (Vice President) sold 1,100 shares of UFP TECHNOLOGIES INC (UFPT) at $317.00 ($0.35M total) on 2026-08-06.
1 min readWhy UFP Technologies Stock Is Skyrocketing Today
UFP Technologies (NASDAQ: UFPT) shares rose about 24% by 2 p.m. ET after the company reported strong Q2 results. UFP said sales grew 15%, adjusted EPS rose 17%, and revenue increased 15% to its five largest customers. The company also reported 12% organic growth and 20% growth in its core medtech unit, and is monitoring tuck-in acquisitions.
4 min read
Biotech Stocks At 52-Week Highs - UFPT +25%, INFU +33%, SOPH +20% On Q2 Reports, REPL, PBLS
Biotech stocks hit 52-week highs Aug 4, 2026 after Q2 results or regulatory updates. UFP Technologies (UFPT) rose over 25% to $338.70, reporting Q2 net income $20.9M and sales $174M. InfuSystem (INFU) gained 33% to $12.49 on $36.9M Q2 revenue and 2026 guidance. Replimune (REPL) jumped to $13.86 after a favorable BLA opinion. SOPHiA (SOPH) rose to $6.98 with $23.3M Q2 revenue and 2026 outlook. Parabilis (PBLS) reached $36.69.
6 min read
Why Is UFP Technologies (UFPT) Stock Soaring Today
UFP Technologies (UFPT) shares rose 18.5% after the company reported Q2 2026 results that beat Wall Street. Revenue increased 15.1% to $174 million, adjusted EPS was $2.92 versus $2.56 expected, and adjusted EBITDA was $36.39 million, 11.5% above forecasts, according to the company.
3 min read
UFP Technologies’s (NASDAQ:UFPT) Q2 CY2026: Strong Sales, Stock Soars
UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results. Revenue rose 15.1% year on year to $174 million, exceeding Wall Street estimates by 9.1% (per the article). Non-GAAP EPS was $2.92, up from $2.50 a year earlier, and 14.2% above consensus. The stock rose 5.3% to $281.50 after results.
4 min read
Earnings To Watch: UFP Technologies (UFPT) Reports Q2 Results Tomorrow
UFP Technologies (NASDAQ: UFPT) will report Q2 results Monday after market hours. The company previously reported $154.2 million revenue, up 4.1% year on year, and beat EPS estimates. For the upcoming quarter, analysts expect revenue growth of 5.4% year on year. UFPT shares are down 6.3% over the past month, with an average price target of $324.50 versus $254.78.
4 min readFELDMANN CYNTHIA L sold $287K of UFPT
FELDMANN CYNTHIA L sold 1,200 shares of UFP TECHNOLOGIES INC (UFPT) at an average of $239.29 ($239.19–$240.40, $0.29M total) across 2 trades on 2026-06-12.
1 min readUFP TECHNOLOGIES INC (UFPT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.4 5 ufpt-20260608x8kxexx104.htm EX-10.4 Document Exhibit 10.4 CERTAIN INFORMATION, IDENTIFIED BY, AND REPLACED WITH, A MARK OF “[**]” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVA
3 min read
Medical-device maker UFP Technologies lines up May 5 investor call
UFP Technologies (NASDAQ: UFPT) announced it will release its first-quarter 2026 financial results on Monday, May 4, 2026, after market close. The company will host a conference call the following day, May 5, 2026, at 8:30 AM Eastern Time to discuss these results. Investors can access dial-in numbers, a live webcast, and a replay on the company's Investor Relations website.
2 min read
UFP Technologies (UFPT) Expected to Announce Quarterly Earnings on Tuesday
UFP Technologies (NASDAQ:UFPT) is expected to announce its Q4 2025 earnings before the market opens on Tuesday, February 24th, with analysts forecasting earnings of $2.26 per share. The company will host an earnings call on February 25th at 9:30 AM ET. Institutional investors hold a significant portion of UFPT stock, with several firms increasing their stakes in Q4, and the stock currently has a "Hold" rating with a consensus target price of $289.00.
3 min read